Quest Diagnostics reported quarterly EPS of $3.12, beating the Zacks consensus estimate of $2.81 by $0.31 (about 11%). This follows $2.62 EPS a year ago, indicating an annual increase of $0.50. Overall, the earnings beat is modestly supportive for DGX near term.
Quest Diagnostics reported quarterly EPS of $3.12, beating the Zacks consensus estimate of $2.81 by $0.31 (about 11%). This follows $2.62 EPS a year ago, indicating an annual increase of $0.50. Overall, the earnings beat is modestly supportive for DGX near term.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
mildly positive
Sentiment Score
0.35
Ticker Sentiment
